# FLOVENT HFA
> **NDA021433** · New Drug Application · Sponsor: GLAXO GRP LTD · Approved 2004-05-14
## Drug
- **FDA Application Number:** NDA021433
- **Application type:** New Drug Application
- **Brand name:** FLOVENT HFA
- **Generic name:** FLUTICASONE PROPIONATE
- **Active ingredients:** FLUTICASONE PROPIONATE
- **Dosage form:** AEROSOL, METERED
- **Route:** INHALATION
- **Marketing status:** Prescription
- **Sponsor:** GLAXO GRP LTD
- **Manufacturer:** Prasco Laboratories
- **First approval:** 2004-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021433)
---
*AI Analytics · CC0 1.0*